PBM Capital Group Invests in Xalud Therapeutics

By | Uncategorized | No Comments

Gene Therapy Platform for Treatment of Neuro-Inflammatory Diseases June 25, 2015 08:00 AM Eastern Daylight Time CHARLOTTESVILLE, VA–(BUSINESS WIRE)—PBM Capital Group, a healthcare-focused private investment firm, announces an investment in Xalud Therapeutics ( This round of financing will help support the company’s gene therapy platform targeting multiple neuro-inflammatory…

Read More